This capital raise (250 bn won) by CHA Biotech is likely to negatively impact the company's share price in the next several weeks as many investors are concerned about excessive shares dilution.
What is covered in the Full Insight:
Introduction
Capital Raise Announcement
Impact on Share Price
Company Background
Key Financials and Valuations
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.